A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.

Source:http://linkedlifedata.com/resource/pubmed/id/11986947

Download in:

View as

General Info

PMID
11986947